123 related articles for article (PubMed ID: 10319410)
41. 17-AAG and 17-DMAG-induced inhibition of cell proliferation through B-Raf downregulation in WT B-Raf-expressing uveal melanoma cell lines.
Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F
Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2348-56. PubMed ID: 18281615
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of Hsp90 function by ansamycins causes retinoblastoma gene product-dependent G1 arrest.
Srethapakdi M; Liu F; Tavorath R; Rosen N
Cancer Res; 2000 Jul; 60(14):3940-6. PubMed ID: 10919672
[TBL] [Abstract][Full Text] [Related]
43. Herbimycin A and geldanamycin inhibit okadaic acid-induced apoptosis and p38 activation in NRK-52E renal epithelial cells.
Davis MA; Carbott DE
Toxicol Appl Pharmacol; 1999 Nov; 161(1):59-74. PubMed ID: 10558924
[TBL] [Abstract][Full Text] [Related]
44. Geldanamycin induces heat shock protein expression through activation of HSF1 in K562 erythroleukemic cells.
Kim HR; Kang HS; Kim HD
IUBMB Life; 1999 Oct; 48(4):429-33. PubMed ID: 10632574
[TBL] [Abstract][Full Text] [Related]
45. JlpA of Campylobacter jejuni interacts with surface-exposed heat shock protein 90alpha and triggers signalling pathways leading to the activation of NF-kappaB and p38 MAP kinase in epithelial cells.
Jin S; Song YC; Emili A; Sherman PM; Chan VL
Cell Microbiol; 2003 Mar; 5(3):165-74. PubMed ID: 12614460
[TBL] [Abstract][Full Text] [Related]
46. The heat-shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin suppresses glial inflammatory responses and ameliorates experimental autoimmune encephalomyelitis.
Dello Russo C; Polak PE; Mercado PR; Spagnolo A; Sharp A; Murphy P; Kamal A; Burrows FJ; Fritz LC; Feinstein DL
J Neurochem; 2006 Dec; 99(5):1351-62. PubMed ID: 17064348
[TBL] [Abstract][Full Text] [Related]
47. [Advances in antitumor activity of the hsp90 inhibitor geldanamycin].
Liao ZY; Zhen YS
Yao Xue Xue Bao; 2001 Sep; 36(9):716-20. PubMed ID: 12580116
[No Abstract] [Full Text] [Related]
48. Stress-induced inhibition of the NF-kappaB signaling pathway results from the insolubilization of the IkappaB kinase complex following its dissociation from heat shock protein 90.
Pittet JF; Lee H; Pespeni M; O'Mahony A; Roux J; Welch WJ
J Immunol; 2005 Jan; 174(1):384-94. PubMed ID: 15611262
[TBL] [Abstract][Full Text] [Related]
49. The Hsp90-specific inhibitor, geldanamycin, blocks CD28-mediated activation of human T lymphocytes.
Schnaider T; Somogyi J; Csermely P; Szamel M
Life Sci; 1998; 63(11):949-54. PubMed ID: 9747895
[TBL] [Abstract][Full Text] [Related]
50. Estrogen and regulation of heat shock protein expression in female cardiomyocytes: cross-talk with NF kappa B signaling.
Hamilton KL; Gupta S; Knowlton AA
J Mol Cell Cardiol; 2004 Apr; 36(4):577-84. PubMed ID: 15081317
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of signal transduction by the Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin results in cytostasis and apoptosis.
Hostein I; Robertson D; DiStefano F; Workman P; Clarke PA
Cancer Res; 2001 May; 61(10):4003-9. PubMed ID: 11358818
[TBL] [Abstract][Full Text] [Related]
52. Heat shock protein 90 (Hsp90) regulates the stability of transforming growth factor beta-activated kinase 1 (TAK1) in interleukin-1beta-induced cell signaling.
Shi L; Zhang Z; Fang S; Xu J; Liu J; Shen J; Fang F; Luo L; Yin Z
Mol Immunol; 2009 Feb; 46(4):541-50. PubMed ID: 18950863
[TBL] [Abstract][Full Text] [Related]
53. Biotinylated geldanamycin.
Clevenger RC; Raibel JM; Peck AM; Blagg BS
J Org Chem; 2004 Jun; 69(13):4375-80. PubMed ID: 15202892
[TBL] [Abstract][Full Text] [Related]
54. Hsp-90-associated oncoproteins: multiple targets of geldanamycin and its analogs.
Blagosklonny MV
Leukemia; 2002 Apr; 16(4):455-62. PubMed ID: 11960322
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of mineralocorticoid and glucocorticoid receptor function by the heat shock protein 90-binding agent geldanamycin.
Bamberger CM; Wald M; Bamberger AM; Schulte HM
Mol Cell Endocrinol; 1997 Aug; 131(2):233-40. PubMed ID: 9296382
[TBL] [Abstract][Full Text] [Related]
56. Identification of a geldanamycin dimer that induces the selective degradation of HER-family tyrosine kinases.
Zheng FF; Kuduk SD; Chiosis G; Münster PN; Sepp-Lorenzino L; Danishefsky SJ; Rosen N
Cancer Res; 2000 Apr; 60(8):2090-4. PubMed ID: 10786665
[TBL] [Abstract][Full Text] [Related]
57. Destabilization of steroid receptors by heat shock protein 90-binding drugs: a ligand-independent approach to hormonal therapy of breast cancer.
Bagatell R; Khan O; Paine-Murrieta G; Taylor CW; Akinaga S; Whitesell L
Clin Cancer Res; 2001 Jul; 7(7):2076-84. PubMed ID: 11448926
[TBL] [Abstract][Full Text] [Related]
58. Geldanamycin and its analogue 17-allylamino-17-demethoxygeldanamycin lowers Bcr-Abl levels and induces apoptosis and differentiation of Bcr-Abl-positive human leukemic blasts.
Nimmanapalli R; O'Bryan E; Bhalla K
Cancer Res; 2001 Mar; 61(5):1799-804. PubMed ID: 11280726
[TBL] [Abstract][Full Text] [Related]
59. Activation of tissue-factor gene expression in breast carcinoma cells by stimulation of the RAF-ERK signaling pathway.
Zhou JN; Ljungdahl S; Shoshan MC; Swedenborg J; Linder S
Mol Carcinog; 1998 Apr; 21(4):234-43. PubMed ID: 9585253
[TBL] [Abstract][Full Text] [Related]
60. Geldanamycin analogs.
Sausville EA
J Chemother; 2004 Nov; 16 Suppl 4():68-9. PubMed ID: 15688614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
